-
Evernorth to offer Humira biosimilar at $0 out of pocket for Accredo patients
The biosimilar price will be about 85% lower than AbbVie’s Humira, the company said. -
NACDS Annual Business Program highlights innovation, engagement amid exponential change
NACDS leadership and guest speakers reflect NACDS’ strength amid exponential change.